Glaukos (GKOS) Income towards Parent Company (2014 - 2026)
Glaukos' (GKOS) quarterly Income towards Parent Company came in at -$19.8 million in Q1 2026, down 9.11% year-on-year from -$21.8 million in Q1 2025, and up 85.76% on a QoQ basis from -$139.0 million in Q4 2025.
Glaukos (GKOS) Income towards Parent Company (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Income towards Parent Company data on file, last reported at -$19.8 million in Q1 2026.
- On a quarterly basis, Income towards Parent Company fell 9.11% year-over-year to -$19.8 million in Q1 2026; TTM through Mar 2026 was -$194.7 million, a 57.46% decrease from a year earlier, with the FY2025 full-year figure at -$193.0 million, down 31.88% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$19.8 million, up from -$139.0 million in the prior quarter.
- Over the last five years, Income towards Parent Company for GKOS reached as high as $5.4 million in Q1 2022 and fell as low as -$139.0 million in Q4 2025.
- Historically, Income towards Parent Company has averaged -$35.0 million across 5 years, with a median of -$32.8 million in 2023.
- Across the five-year window, Income towards Parent Company soared 132.81% in 2022 and slumped 740.87% in 2023, its largest moves.
- Year by year, Income towards Parent Company stood at -$34.3 million in 2022, then decreased by 7.0% to -$36.8 million in 2023, then grew by 8.63% to -$33.6 million in 2024, then sank by 313.96% to -$139.0 million in 2025, then surged by 85.76% to -$19.8 million in 2026.
- Per Business Quant data, the three most recent Income towards Parent Company figures were -$19.8 million in Q1 2026, -$139.0 million in Q4 2025, and -$16.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Glaukos | 8.79 Bn | 8.68 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.80 Mn |
| Dec 31, 2025 | -139.01 Mn |
| Sep 30, 2025 | -16.23 Mn |
| Jun 30, 2025 | -19.66 Mn |
| Mar 31, 2025 | -18.15 Mn |
| Dec 31, 2024 | -33.58 Mn |
| Sep 30, 2024 | -21.41 Mn |
| Jun 30, 2024 | -50.51 Mn |
| Mar 31, 2024 | -40.84 Mn |
| Dec 31, 2023 | -36.75 Mn |
| Sep 30, 2023 | -30.44 Mn |
| Jun 30, 2023 | -32.81 Mn |
| Mar 31, 2023 | -34.63 Mn |
| Dec 31, 2022 | -34.35 Mn |
| Sep 30, 2022 | -27.53 Mn |
| Jun 30, 2022 | -45.54 Mn |
| Mar 31, 2022 | 5.40 Mn |
| Dec 31, 2021 | -21.87 Mn |
| Sep 30, 2021 | 6.23 Mn |
| Jun 30, 2021 | -17.48 Mn |